Skip to Main content Skip to Navigation
Journal articles

Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects

Abstract : Despite striking results, clinical outcome with immune checkpoint inhibitors remains too often uncertain. This joint-project aims at generating dense longitudinal data in lung cancer patients undergoing anti-PD1 or anti-PDL1 therapy, alone or in combination with other anticancer agents. Mathematical modelling with mechanistic learning algorithms will be used next to decipher the mechanisms underlying response or resistance to immunotherapy. Ultimately, this project should help to better understand the mechanisms underlying resistance to immune checkpoint inhibitors and identify a serial of actionable items to increase the efficacy of immunotherapy.
Complete list of metadata

https://hal.inria.fr/hal-03147110
Contributor : Sebastien Benzekry Connect in order to contact the contributor
Submitted on : Friday, February 19, 2021 - 3:43:26 PM
Last modification on : Saturday, December 4, 2021 - 3:43:29 AM
Long-term archiving on: : Thursday, May 20, 2021 - 7:46:12 PM

File

Main text BJC comment ciccolin...
Files produced by the author(s)

Identifiers

Citation

Joseph Ciccolini, Sébastien Benzekry, Fabrice Barlesi. Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects. British Journal of Cancer, Cancer Research UK, 2020, 123 (3), pp.337-338. ⟨10.1038/s41416-020-0918-3⟩. ⟨hal-03147110⟩

Share

Metrics

Les métriques sont temporairement indisponibles